<?xml version="1.0" encoding="UTF-8"?>
<p id="par0045">The SARS-CoV2 enters human pneumocytes through a process called endocytosis using its spike glycoproteins (S-glycoprotein) which then bind angiotensin-converting enzyme 2 (ACE2) that are expressed on pneumocytes (
 <xref rid="bib0135" ref-type="bibr">Hamming et al., 2004</xref>; 
 <xref rid="bib0260" ref-type="bibr">Li et al., 2003</xref>; 
 <xref rid="bib0325" ref-type="bibr">Ou et al., 2020</xref>). Notably, ACE2 is widely expressed on the epithelial cells of alveoli, trachea, bronchi, bronchial serous glands (
 <xref rid="bib0270" ref-type="bibr">Liu et al., 2011</xref>), and alveolar monocytes and macrophages (
 <xref rid="bib0230" ref-type="bibr">Kuba et al., 2005</xref>). The fusion of the viral E proteins and endosomal phospholipidic membrane allows the release of the viral + RNA into the host cell cytoplasm.
</p>
